471 related articles for article (PubMed ID: 18509272)
1. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
5. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
Franchi A; Gallo O; Boddi V; Santucci M
Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
7. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
[TBL] [Abstract][Full Text] [Related]
8. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
9. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
10. [Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].
Yoshikawa H; Ikeuchi T; Iguchi H; Onodera Y; Kai Y
Hinyokika Kiyo; 1995 Apr; 41(4):253-8. PubMed ID: 7785554
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p53 and c-erbB-2 in breast carcinoma: relation with epidemiologic factors, histologic features and prognosis.
Fernández Aceñero MJ; Farina González J; Arangoncillo Ballesteros P
Gen Diagn Pathol; 1997 Jun; 142(5-6):289-96. PubMed ID: 9228251
[TBL] [Abstract][Full Text] [Related]
14. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index.
Alexiev BA; Bassarova AV; Popovska SL; Popov AA; Christov CZ
Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249
[TBL] [Abstract][Full Text] [Related]
16. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
18. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma.
Liu M; Lawson G; Delos M; Jamart J; Remacle M
Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]